Similar tumor suppressing activity has been well documented for another HSP40 members—DNAJB6, overexpression of which reduces malignancy and is responsible for partial reversal of the mesenchymal phenotypes in breast cancer, in vitro and in vivo [68,69] (Figure 3). This evidence concerns the gene DNAJB6 and neoplasm.